140 women win payouts for vaginal mesh complications Women claimed the implants caused infection, bleeding, chronic pain, bladder and bowel perforations, and problems urinating The Independent UK · Aug 19, 2024
140 women in England receive payout for vaginal mesh implant complications Settlement from first successful group claim in England expected to total millions of pounds, but size of payments unknown The Guardian - UK · Aug 19, 2024
Big Pharma fought to keep prices high Big Pharma exploited patent laws to stifle competition amid Medicare price negotiations, according to a new report Salon · Aug 15, 2024
Once Valued At $21B, Avon Files For Bankruptcy Following Lawsuits For 'Cancer-causing' Products Avon Products Inc. is declaring bankruptcy in the face of numerous lawsuits claiming that the talcum powder in its products causes cancer. International Business Times UK · Aug 15, 2024
3 Bargain Healthcare Stocks to Buy for Long-Term Gains The healthcare sector is poised for significant growth, driven by advancements in drug development, ongoing research and development (R&D) efforts, and its ability to remain resilient even during economic downturns. Thus, investors might consider buying bargain pharma stocks: Johnson & Johnson (JNJ), Merck & Co. (MRK), and AbbVie (ABBV) for… StockNews.com · Aug 13, 2024
Is It Time to Buy These Overlooked Dividend Stocks? These defensive healthcare picks from the Dow Jones Industrial Average are worth a look at current levels for investors seeking passive income. Barchart · Aug 7, 2024
3 Top Stocks for Dividend Reinvestment Plans (DRIPs) DRIPs offer a compelling strategy to boost investment returns. This approach helps to compound your gains over time by reinvesting dividends to buy more stock and reducing risk through dollar-cost investing. Top stocks, including Johnson & Johnson (JNJ), Coca-Cola (KO), and PepsiCo (PEP), are ideal for reinvesting dividends to maximize… StockNews.com · Aug 6, 2024
Is Wall Street Bullish or Bearish on Johnson & Johnson Stock? Despite Johnson & Johnson’s relative underperformance over the past year, Wall Street analysts remain moderately optimistic about the stock’s prospects. Barchart · Aug 6, 2024
3 Healthcare Stocks Benefiting From an Aging Population The healthcare industry is set for growth due to the growing demand for quality healthcare services and the aging population. Hence, quality healthcare stocks, such as Johnson & Johnson (JNJ), AbbVie (ABBV), and Merck & Co. (MRK), might be worth looking into. Read more…. StockNews.com · Jul 25, 2024
3 Pharmaceutical Stocks With Strong Pipelines The pharmaceutical industry is flourishing due to increasing medical demands and rising healthcare spending worldwide. Hence, pharma stocks Eli Lilly (LLY), Johnson & Johnson (JNJ), and Merck & Co. (MRK), with strong pipelines, might be worth buying. Read more…. StockNews.com · Jul 18, 2024
Stock Market Today: Semis Get Slammed and Blue Chips Bounce The potential for more curbs on tech sales to China set off a rotation into blue chips. Kiplinger · Jul 17, 2024
Broader Market Slides as Chip Stocks Plunge The S&P 500 Index ($SPX ) (SPY ) today is down -1.13%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.26%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.29%. Stock indexes today are mixed, with the Dow Jones Industrials posting a new record... Barchart · Jul 17, 2024
Johnson & Johnson Earnings Preview: What to Expect Johnson & Johnson is expected to release its second-quarter earnings next week, and analysts project a low single-digit profit dip. Barchart · Jul 9, 2024
WHO Agency Says Talc Is 'Probably' Cancer-causing The World Health Organization's cancer agency on Friday classified talc as "probably carcinogenic" for humans, however an outside expert warned against misinterpreting the announcement as a "smoking gun". International Business Times · Jul 5, 2024
Barchart · Jun 21, 2024 3 Highest-yield Dividend Kings To Buy This Summer Looking for income this summer? Here are three quality companies that'll put a few extra dollars in your pocket.
Kiplinger · Jun 16, 2024 How 4 Ordinary People Invested To Reach Financial Goals Patience helped these four investors make their portfolios work for them.
StockNews.com · Jun 13, 2024 3 Blue-Chip Stocks Offering Stability Blue-chip companies, characterized by large capitalization, global footprint, solid financial performance, robust balance sheet, and dominant market position, are favored by investors seeking stability and long-term growth potential. Thus, quality blue-chip stocks Microsoft (MSFT), Procter & Gamble (PG), and Johnson & Johnson (JNJ) could be attractive buys for steady returns.…
Al Jazeera · Jun 12, 2024 Johnson & Johnson to pay $700m to settle claims it misled consumers Pharmaceutical giant’s payout settles allegations it misled consumers about safety of its talcum-based powder products.
StockNews.com · May 27, 2024 Top 4 Pharma Stocks for Long-Term Value Investors in 2024 The pharmaceutical sector is experiencing rapid growth thanks to the rising demand for precision drugs, the growing geriatric population, and an uptick in chronic diseases. Given this backdrop, long-term value investors could consider buying and holding quality pharmaceutical stocks such as Organon (OGN), Procaps (PROC), Johnson & Johnson (JNJ), and…
Top News · May 23, 2024 Cancer Victims Sue Johnson & Johnson Over Bankruptcy Allegations Johnson & Johnson faces legal action over alleged fraudulent bankruptcies related to talc products causing cancer.
Barchart · May 11, 2024 5 Standout Healthcare Dividend Stocks to Consider Now Amid healthcare’s enduring importance and increasing demand for its products and services, here are five dividend-paying healthcare stocks to consider now.
International Business Times · May 1, 2024 J&J Unveils Landmark $6.5 Billion Settlement With Baby Powder Ovarian Cancer Claimants J&J has reached a new $6.5 billion settlement with those who claimed that the company's baby powder causes ovarian cancer.
The Guardian - UK · Apr 21, 2024 Medical device companies pay millions to NHS while pushing products, says study Pharmaceutical equipment firms are funding NHS staff and training while promoting sales
Top News · Apr 20, 2024 WHO To Issue Alert On Contaminated J&J Cough Syrup WHO may issue a broader alert for contaminated Johnson & Johnson cough syrup in Africa, highlighting public health risks and the importance of regulatory v...
Top News · Apr 19, 2024 J&J Prevails In Talc Lawsuit Over Cancer Allegations Johnson & Johnson wins trial over cancer claims related to baby powder in Florida. Company maintains product safety amidst ongoing legal battles.